| Rockwell Medical Prices Registered Common Stock Offering - MarketWatch (press release) |
|
|
MarketWatch (press release) WIXOM, Mich., Feb 9, 2012 (GlobeNewswire via COMTEX) -- Rockwell Medical Technologies, Inc. /quotes/zigman/66259/quotes/nls/rmti RMTI +3.20% , a fully-integrated biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney |